Historique
Article de Périodique
Focus on ketamine (2006)
(Focus sur la kétamine.)
Auteur(s) :
National Collaborating Centre for Drug Prevention (NCCDP)
Année
2006
Page(s) :
24-26
Langue(s) :
Anglais
Refs biblio. :
8
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note générale :
Drug Prevention Quarterly, 2006, (4), 24-26, ill.
Résumé :
Ketamine is also known as K, Special K, Green, Super K, Vitamin K. Previously controlled under the medicines act 1968, since 1st January 2006 ketamine has been a Class C drug. It is a powerful dissociative drug with anaesthetic and hallucinogenic properties, used as an anaesthetic for both animals and humans. Moderate doses produce feelings of energy and euphoria, followed by sedation. Higher or repeat doses can produce powerful hallucinations. Effects will vary according to method of administration. Ketamine can cause nausea, vomiting, disorientation, detachment, numbness/temporary paralysis, slurred speech, lack of coordination and unconsciousness. Combination of anaesthetic properties and hallucination increase risks of accident and injury. Long-term effects may include memory, attention and vision impairment. It can cause panic attacks and depression. Large doses may exacerbate existing mental health problems. Physical dependence and withdrawal are not features of ketamine use. Unlike other hallucinogens, psychological dependence may occur. Average UK street price is around £30 per gram. In animals ketamine has been found to destroy a specific group of brain cells in the limbic cortex, it is not known whether similar neurotoxic effects exist in humans (Olney & Farber, 1995). (Extract of the publication)
Affiliation :
NCCDP, Centre for Public Health, Liverpool JMU, Castle House, North Street, Liverpool L3 2AY
Royaume-Uni. United Kingdom.
Royaume-Uni. United Kingdom.